Humana Inc (NYSE:HUM) insider Roy A. Beveridge sold 8,278 shares of the company’s stock in a transaction that occurred on Tuesday, February 19th. The stock was sold at an average price of $307.16, for a total transaction of $2,542,670.48. Following the sale, the insider now owns 12,409 shares in the company, valued at $3,811,548.44. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.
Shares of NYSE HUM traded up $2.17 during mid-day trading on Friday, hitting $309.73. 309,542 shares of the company were exchanged, compared to its average volume of 931,763. The company has a debt-to-equity ratio of 0.43, a current ratio of 1.68 and a quick ratio of 1.68. Humana Inc has a 1-year low of $261.35 and a 1-year high of $355.88. The company has a market cap of $41.87 billion, a PE ratio of 21.29, a P/E/G ratio of 1.27 and a beta of 1.05.
Humana (NYSE:HUM) last issued its quarterly earnings results on Wednesday, February 6th. The insurance provider reported $2.65 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $2.53 by $0.12. The firm had revenue of $14.17 billion during the quarter, compared to the consensus estimate of $14.04 billion. Humana had a return on equity of 19.64% and a net margin of 2.96%. The company’s revenue for the quarter was up 7.4% on a year-over-year basis. During the same period last year, the company earned $2.06 earnings per share. Analysts anticipate that Humana Inc will post 17.49 earnings per share for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 26th. Shareholders of record on Friday, March 29th will be given a $0.55 dividend. This is a boost from Humana’s previous quarterly dividend of $0.50. The ex-dividend date of this dividend is Thursday, March 28th. This represents a $2.20 annualized dividend and a yield of 0.71%. Humana’s dividend payout ratio is presently 6.87%.
A number of large investors have recently added to or reduced their stakes in HUM. Moody National Bank Trust Division purchased a new position in shares of Humana in the fourth quarter valued at $30,000. We Are One Seven LLC purchased a new position in shares of Humana in the fourth quarter valued at $31,000. Proficio Capital Partners LLC increased its position in shares of Humana by 81.4% in the fourth quarter. Proficio Capital Partners LLC now owns 107 shares of the insurance provider’s stock valued at $31,000 after buying an additional 48 shares in the last quarter. Exane Asset Management purchased a new position in shares of Humana in the fourth quarter valued at $43,000. Finally, Sontag Advisory LLC purchased a new position in shares of Humana in the fourth quarter valued at $47,000. Hedge funds and other institutional investors own 92.23% of the company’s stock.
A number of analysts recently weighed in on HUM shares. upped their target price on shares of Humana from $350.00 to $373.00 and gave the stock an “outperform” rating in a research note on Thursday, November 8th. Jefferies Financial Group upped their price target on Humana from $388.00 to $410.00 and gave the company a “buy” rating in a report on Thursday, November 8th. Bank of America upped their price target on Humana from $400.00 to $415.00 and gave the company a “buy” rating in a report on Thursday, November 8th. Credit Suisse Group upped their price target on Humana from $370.00 to $390.00 and gave the company an “outperform” rating in a report on Thursday, November 8th. Finally, Royal Bank of Canada upped their price target on Humana from $318.00 to $349.00 and gave the company a “sector perform” rating in a report on Thursday, November 8th. Five investment analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company. The stock has an average rating of “Buy” and a consensus price target of $355.06.
Humana Inc, together with its subsidiaries, operates as a health and well-being company in the United States. The company operates through four segments: Retail; Group and Specialty; Healthcare Services; and Individual Commercial. The Retail segment offers Medicare and supplemental benefit plans to individuals or through group accounts.
Featured Story: Trading Ex-Dividend
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.